Centro Medico Imbanaco de Cali S.A (Site 2909)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Ovarian cancer

Closed trials

• Completed

  Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

  NCT03740165· Phase 3· Merck Sharp & Dohme LLC· Source